Results 11 to 20 of about 2,547,606 (153)

Determinants of response to CDK4/6 inhibitors in the real-world setting

open access: yesnpj Precision Oncology, 2023
Despite widespread use and a known mechanism of action for CDK4/6 inhibitors in combination with endocrine therapy, features of disease evolution and determinants of therapeutic response in the real-world setting remain unclear.
A. Witkiewicz   +6 more
semanticscholar   +1 more source

TP53 mutation is associated with improved disease control in patients with advanced RAS wild-type colorectal adenocarcinoma treated with cetuximab and pembrolizumab. [PDF]

open access: yesInt J Cancer
Immunotherapy with checkpoint inhibitors targeting the PD1/PD‐L1 and CTLA4 pathways has limited activity in patients with microsatellite stable (MSS) colorectal adenocarcinoma (CRC). In a prior study, the combination of cetuximab and pembrolizumab failed
Fountzilas C   +24 more
europepmc   +2 more sources

Cancer cell cycle dystopia: heterogeneity, plasticity, and therapy

open access: yesTrends in Cancer, 2022
The mammalian cell cycle has been extensively studied regarding cancer etiology, progression, and therapeutic intervention. The canonical cell cycle framework is supported by a plethora of data pointing to a relatively simple linear pathway in which ...
A. Witkiewicz   +3 more
semanticscholar   +1 more source

Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trial. [PDF]

open access: yesNat Commun
CDK4/6 inhibitors (CDK4/6i) improve outcomes for estrogen receptor (ER) positive/HER2-negative breast cancers (BCs), yet intrinsic and acquired resistance exist.
Kong T   +33 more
europepmc   +2 more sources

The history and future of targeting cyclin-dependent kinases in cancer therapy

open access: yesNature reviews. Drug discovery, 2015
Cancer represents a pathological manifestation of uncontrolled cell division; therefore, it has long been anticipated that our understanding of the basic principles of cell cycle control would result in effective cancer therapies.
U. Asghar   +3 more
semanticscholar   +1 more source

[“Witkacy darted like a gap-toothed person onto rusk”. Witkiewicz during the First World War

open access: yesPrzestrzenie Teorii, 2010
This text is a polemic with an article by Maria A. Potocka “Ja” jako materiał twórczy [“I”as a material for creation]. When considering the problem of the presence of Witkacy in the Tsarist army, the author comes to a conclusion that Witkiewicz went ...
Stefan Okołowicz
doaj   +1 more source

The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma

open access: yesCell Cycle, 2009
Here, we propose a new model for understanding the Warburg effect in tumor metabolism. Our hypothesis is that epithelial cancer cells induce the Warburg effect (aerobic glycolysis) in neighboring stromal fibroblasts.
S. Pavlides   +13 more
semanticscholar   +1 more source

Witkacy’s Attempt at a Subject – a Subject for a Test

open access: yesPrzestrzenie Teorii, 2010
In the article Witkacego próba podmiotu – podmiot na próbę [Witkacy’s Attempt at a Subject – a Subject for a Test] the subjective identity of S.I. Witkiewicz is characterised by means of the widely understood category of a trial.
Irena Górska
doaj   +1 more source

Torments of Education (“Metaphysics of a Two-Headed Calf” by S.I. Witkiewicz)

open access: yesPrzestrzenie Teorii, 2010
Identity crisis, one of the crucial problems tackled by Witkacy in his dramas, is linked first of all with the tradition of modernism by critics. The author of the article suggests a change in the viewpoint, and basing on the analysis of Metaphysics of a
Ewa Wąchocka
doaj   +1 more source

Acetate Dependence of Tumors

open access: yesCell, 2014
SUMMARY Acetyl-CoA represents a central node of carbon metabolism that plays a key role in bioenergetics, cell proliferation and the regulation of gene expression.
S. Comerford   +13 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy